Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
34
2024
2231
5.180
Why?
Machine Learning
7
2024
488
2.310
Why?
Stroke Volume
17
2025
612
2.000
Why?
Methadone
5
2023
99
1.570
Why?
Adrenergic beta-Antagonists
10
2025
323
1.540
Why?
Pregnancy Complications, Cardiovascular
5
2022
78
1.510
Why?
Buprenorphine
3
2023
169
1.400
Why?
Cardiomyopathies
5
2022
348
1.370
Why?
Decision Support Systems, Clinical
6
2024
223
1.270
Why?
United States Food and Drug Administration
5
2024
208
1.260
Why?
Pharmacogenetics
5
2024
179
1.170
Why?
Cardiomyopathy, Dilated
9
2025
383
1.160
Why?
Adverse Drug Reaction Reporting Systems
4
2024
77
1.140
Why?
Arrhythmias, Cardiac
6
2023
333
1.120
Why?
Electronic Health Records
7
2024
1046
1.050
Why?
Cytochrome P-450 CYP2C19
4
2024
24
1.020
Why?
Hospitalization
10
2024
2184
0.920
Why?
Propanolamines
3
2019
96
0.910
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
443
0.890
Why?
Workflow
1
2024
165
0.830
Why?
Telemedicine
4
2024
852
0.810
Why?
Torsades de Pointes
4
2016
24
0.750
Why?
Seasons
1
2024
544
0.750
Why?
Pulmonary Edema
1
2021
107
0.720
Why?
Humans
85
2025
136803
0.720
Why?
Coffee
1
2021
17
0.710
Why?
Stroke
2
2021
1133
0.680
Why?
Pharmacogenomic Testing
4
2022
64
0.680
Why?
Platelet Aggregation Inhibitors
1
2024
462
0.660
Why?
Defibrillators, Implantable
2
2021
315
0.660
Why?
Aged
31
2025
23808
0.640
Why?
Prosthesis Failure
1
2020
123
0.620
Why?
Prosthesis-Related Infections
1
2020
95
0.610
Why?
Long QT Syndrome
3
2016
70
0.610
Why?
Device Removal
1
2020
136
0.610
Why?
Mobile Applications
1
2021
182
0.600
Why?
Spironolactone
1
2019
36
0.600
Why?
Pacemaker, Artificial
1
2020
119
0.600
Why?
United States
21
2024
14691
0.600
Why?
Mineralocorticoid Receptor Antagonists
1
2019
54
0.590
Why?
Medical Records
2
2019
174
0.590
Why?
Coronary Disease
1
2021
384
0.580
Why?
Diabetes Mellitus
2
2024
1033
0.580
Why?
Biomedical Research
2
2024
688
0.580
Why?
Periodicals as Topic
1
2020
208
0.570
Why?
Mortality
3
2019
361
0.560
Why?
Retrospective Studies
21
2024
15510
0.550
Why?
Risk Assessment
8
2024
3434
0.540
Why?
Hypertension, Pregnancy-Induced
1
2018
68
0.530
Why?
Female
48
2025
72816
0.530
Why?
Receptors, Transforming Growth Factor beta
1
2017
59
0.520
Why?
Analgesics, Opioid
2
2023
993
0.520
Why?
Hospital Records
1
2016
12
0.520
Why?
Proteoglycans
1
2017
107
0.510
Why?
Atrial Fibrillation
3
2019
389
0.510
Why?
Ventricular Function, Left
5
2025
533
0.510
Why?
Hospital Mortality
6
2024
901
0.510
Why?
Artificial Intelligence
1
2019
275
0.500
Why?
Disease Management
1
2020
624
0.480
Why?
Survival
1
2015
38
0.480
Why?
Tetrazoles
1
2015
40
0.480
Why?
Middle Aged
29
2025
33239
0.480
Why?
Male
40
2025
67330
0.470
Why?
Biphenyl Compounds
1
2015
63
0.470
Why?
Muscle Proteins
2
2025
228
0.460
Why?
Myocardial Infarction
3
2018
1044
0.460
Why?
Research Design
1
2020
1127
0.430
Why?
Ventricular Remodeling
3
2025
262
0.430
Why?
Registries
2
2020
2015
0.420
Why?
Loperamide
2
2023
11
0.420
Why?
Myocardium
3
2017
1001
0.410
Why?
Adult
28
2024
37643
0.410
Why?
Tachycardia, Ventricular
1
2015
175
0.400
Why?
Diet
1
2021
1274
0.400
Why?
Precision Medicine
6
2024
426
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2184
0.400
Why?
Legislation, Medical
1
2012
11
0.390
Why?
Amiodarone
1
2012
26
0.390
Why?
Peripartum Period
4
2022
17
0.390
Why?
Quality Improvement
2
2020
1163
0.380
Why?
Patient Readmission
1
2018
694
0.380
Why?
Phenotype
5
2025
3189
0.380
Why?
Anti-Arrhythmia Agents
1
2012
114
0.370
Why?
Heart Arrest
4
2019
338
0.360
Why?
Catheter Ablation
1
2015
349
0.360
Why?
Sex Factors
4
2024
2064
0.350
Why?
Pyrazines
2
2008
90
0.350
Why?
Treatment Outcome
10
2025
10748
0.350
Why?
Transfusion Reaction
1
2011
46
0.340
Why?
Triazoles
2
2008
147
0.340
Why?
Cardiovascular Diseases
5
2024
2105
0.340
Why?
Forecasting
2
2024
388
0.340
Why?
Postoperative Complications
2
2020
2639
0.330
Why?
Heart-Assist Devices
1
2016
552
0.330
Why?
Echocardiography
3
2024
643
0.330
Why?
Patient Transfer
1
2012
168
0.330
Why?
Insurance, Health
1
2012
280
0.330
Why?
Patient Discharge
2
2021
894
0.320
Why?
Databases, Factual
5
2020
1351
0.310
Why?
Anemia
1
2011
170
0.310
Why?
Risk Factors
9
2024
10332
0.310
Why?
Thiazolidinediones
1
2010
137
0.310
Why?
Aged, 80 and over
7
2024
7593
0.300
Why?
Marketing
1
2008
30
0.300
Why?
Renal Insufficiency
1
2011
155
0.300
Why?
Genotype
3
2024
1914
0.300
Why?
Rhabdomyolysis
1
2008
21
0.300
Why?
Simvastatin
1
2008
61
0.290
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.290
Why?
Heart Ventricles
4
2017
785
0.290
Why?
Receptors, Adrenergic, beta-1
4
2019
46
0.280
Why?
Heart Rate
3
2025
820
0.280
Why?
Length of Stay
4
2024
1205
0.280
Why?
Electrocardiography
4
2019
629
0.280
Why?
Cytochrome P-450 CYP2D6
3
2022
30
0.280
Why?
Drug Industry
1
2008
111
0.280
Why?
Kaplan-Meier Estimate
3
2016
888
0.280
Why?
Proportional Hazards Models
4
2021
1262
0.270
Why?
Practice Patterns, Physicians'
3
2020
1301
0.270
Why?
Pharmacovigilance
2
2024
23
0.260
Why?
Elective Surgical Procedures
2
2020
180
0.250
Why?
Follow-Up Studies
6
2024
5106
0.250
Why?
Incidence
5
2024
2797
0.250
Why?
Biological Specimen Banks
3
2024
102
0.250
Why?
Emergency Service, Hospital
2
2020
2048
0.250
Why?
Patient Reported Outcome Measures
2
2020
402
0.240
Why?
Gene Expression Regulation
1
2015
2605
0.240
Why?
Cause of Death
2
2019
430
0.230
Why?
Glucose
1
2010
1019
0.230
Why?
New York
1
2024
126
0.220
Why?
Diabetic Cardiomyopathies
1
2024
36
0.220
Why?
Pandemics
3
2022
1616
0.220
Why?
Young Adult
9
2022
13129
0.220
Why?
Pregnancy
6
2022
6729
0.220
Why?
Acute Kidney Injury
2
2008
809
0.210
Why?
Diphenoxylate
1
2023
5
0.210
Why?
Randomized Controlled Trials as Topic
3
2021
1462
0.210
Why?
Adolescent
10
2020
21385
0.210
Why?
Monitoring, Physiologic
1
2024
267
0.200
Why?
Nonprescription Drugs
1
2023
63
0.200
Why?
Heart Defects, Congenital
2
2020
833
0.200
Why?
Medicare
2
2020
758
0.190
Why?
Prognosis
5
2020
4013
0.190
Why?
Naltrexone
1
2023
97
0.190
Why?
Insulin Resistance
1
2010
1203
0.180
Why?
Time Factors
3
2020
6809
0.180
Why?
Speech
1
2021
70
0.180
Why?
Red Meat
1
2021
18
0.180
Why?
Smartphone
1
2021
92
0.170
Why?
Drug Dosage Calculations
1
2020
23
0.170
Why?
Losartan
1
2020
14
0.170
Why?
Lisinopril
1
2020
13
0.170
Why?
Data Interpretation, Statistical
2
2020
363
0.170
Why?
Hypoglycemic Agents
1
2010
1283
0.170
Why?
Actigraphy
1
2021
110
0.170
Why?
Protective Factors
1
2021
93
0.170
Why?
Angioedema
1
2020
16
0.170
Why?
Hypertension
2
2020
1285
0.170
Why?
Cardiac Resynchronization Therapy
1
2021
46
0.170
Why?
Wearable Electronic Devices
1
2021
53
0.170
Why?
Turner Syndrome
1
2021
53
0.170
Why?
American Heart Association
2
2019
306
0.170
Why?
Referral and Consultation
2
2017
780
0.170
Why?
Data Accuracy
1
2020
65
0.170
Why?
Milk
1
2021
124
0.170
Why?
Biological Products
1
2023
215
0.160
Why?
Indans
1
2020
11
0.160
Why?
California
2
2012
429
0.160
Why?
Oxadiazoles
1
2020
33
0.160
Why?
Bionics
1
2019
12
0.160
Why?
Editorial Policies
1
2020
51
0.160
Why?
Medical Futility
1
2019
23
0.160
Why?
Medical Informatics
1
2020
101
0.160
Why?
Fingolimod Hydrochloride
1
2020
40
0.160
Why?
Software
2
2015
665
0.160
Why?
Medical Record Linkage
1
2020
64
0.160
Why?
Prescription Drugs
1
2020
109
0.160
Why?
Information Storage and Retrieval
1
2020
117
0.160
Why?
Drug Overdose
1
2023
345
0.150
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
76
0.150
Why?
Drug Prescriptions
1
2021
244
0.150
Why?
Sitagliptin Phosphate
2
2008
33
0.150
Why?
Medical Order Entry Systems
1
2019
43
0.150
Why?
Child Health Services
1
2020
184
0.150
Why?
Social Determinants of Health
1
2022
257
0.150
Why?
Dose-Response Relationship, Drug
4
2020
2052
0.150
Why?
Tobacco Use
1
2019
64
0.150
Why?
Cohort Studies
3
2021
5704
0.150
Why?
Computer Graphics
2
2015
42
0.140
Why?
Cluster Analysis
1
2019
497
0.140
Why?
Gene Regulatory Networks
2
2023
304
0.140
Why?
Receptors, Histamine H2
1
2017
8
0.140
Why?
Florida
1
2018
103
0.140
Why?
Advisory Committees
1
2019
219
0.140
Why?
Porins
1
1997
13
0.140
Why?
Neisseria gonorrhoeae
1
1997
25
0.140
Why?
Dyslipidemias
1
2019
176
0.130
Why?
Prospective Studies
4
2021
7573
0.130
Why?
Academic Medical Centers
1
2020
504
0.130
Why?
Nursing Assessment
1
2017
57
0.130
Why?
Antihypertensive Agents
1
2020
488
0.130
Why?
Patient Participation
1
2020
418
0.130
Why?
Pressure Ulcer
1
2017
46
0.130
Why?
Heart Diseases
1
2020
346
0.130
Why?
Population Surveillance
1
2020
474
0.130
Why?
Cardiology
1
2019
274
0.130
Why?
Hospitals, Teaching
1
2017
117
0.130
Why?
Tilidine
1
2016
2
0.130
Why?
Consensus
1
2019
678
0.120
Why?
Double-Blind Method
3
2025
1982
0.120
Why?
Genetic Markers
1
2017
344
0.120
Why?
Oxycodone
1
2016
42
0.120
Why?
Databases, Genetic
1
2017
237
0.120
Why?
Rheumatic Heart Disease
1
2015
7
0.120
Why?
Rheumatic Fever
1
2015
10
0.120
Why?
Sex Distribution
1
2016
374
0.120
Why?
Cholesterol Ester Transfer Proteins
1
2015
20
0.120
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.120
Why?
Hospitals, Low-Volume
1
2015
22
0.120
Why?
Angiotensin II
1
2015
99
0.120
Why?
Naloxone
1
2016
121
0.120
Why?
Computational Biology
2
2017
643
0.120
Why?
Gene Expression Profiling
3
2017
1772
0.110
Why?
Hospitals, High-Volume
1
2015
44
0.110
Why?
Marijuana Use
1
2018
203
0.110
Why?
Immunosuppressive Agents
1
2020
889
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
766
0.110
Why?
Percutaneous Coronary Intervention
1
2020
478
0.110
Why?
Mothers
1
2020
752
0.110
Why?
United Kingdom
1
2015
310
0.110
Why?
International Classification of Diseases
1
2015
132
0.110
Why?
Biomarkers
2
2024
4145
0.110
Why?
Age Factors
2
2019
3286
0.110
Why?
Comorbidity
1
2019
1614
0.110
Why?
Chronic Disease
2
2020
1786
0.100
Why?
Narcotic Antagonists
1
2015
179
0.100
Why?
Gene Expression
2
2017
1500
0.100
Why?
Ventricular Dysfunction, Left
2
2020
382
0.100
Why?
Down-Regulation
1
2015
656
0.100
Why?
Cholesterol
1
2015
410
0.100
Why?
MicroRNAs
2
2017
692
0.100
Why?
Coronary Artery Disease
1
2019
698
0.100
Why?
Federal Government
1
2012
28
0.100
Why?
Myocytes, Cardiac
1
2017
523
0.100
Why?
RNA, Messenger
2
2017
2831
0.100
Why?
Drug Resistance
1
2012
169
0.090
Why?
Area Under Curve
1
2012
314
0.090
Why?
Patient Safety
1
2015
308
0.090
Why?
Genetic Predisposition to Disease
2
2017
2412
0.090
Why?
Predictive Value of Tests
1
2017
2022
0.090
Why?
Colorado
4
2024
4515
0.090
Why?
Opiate Substitution Treatment
1
2013
151
0.090
Why?
Gastrointestinal Hemorrhage
1
2012
132
0.090
Why?
Anti-Retroviral Agents
1
2013
233
0.090
Why?
Pregnancy Outcome
1
2013
412
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
1036
0.090
Why?
Survival Rate
1
2015
1964
0.090
Why?
Bayes Theorem
1
2012
404
0.090
Why?
Managed Care Programs
2
2022
130
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
228
0.080
Why?
Genome-Wide Association Study
1
2017
1428
0.080
Why?
Delivery of Health Care
1
2017
935
0.080
Why?
Emergency Medical Services
1
2015
547
0.080
Why?
Multivariate Analysis
1
2012
1507
0.080
Why?
Severity of Illness Index
1
2017
2822
0.080
Why?
Pharmacogenomic Variants
2
2019
35
0.070
Why?
Primary Health Care
1
2019
1722
0.070
Why?
Drug Approval
1
2008
87
0.070
Why?
Vasodilator Agents
1
2010
331
0.070
Why?
Logistic Models
1
2012
2067
0.070
Why?
Kidney Function Tests
1
2007
159
0.070
Why?
Animals
3
2023
36850
0.070
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
250
0.060
Why?
Zimbabwe
2
2017
58
0.060
Why?
Opioid-Related Disorders
1
2013
509
0.060
Why?
Drug Therapy, Combination
1
2008
1062
0.060
Why?
Models, Biological
1
2012
1773
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.060
Why?
Case-Control Studies
1
2012
3540
0.060
Why?
Depression
2
2022
1397
0.060
Why?
Psychological Tests
1
2005
140
0.060
Why?
Osteoporosis, Postmenopausal
1
2004
41
0.050
Why?
Potassium Channels
1
2025
151
0.050
Why?
Cross-Sectional Studies
3
2022
5424
0.050
Why?
Mandible
1
2004
78
0.050
Why?
Receptors, Adrenergic
1
2023
33
0.050
Why?
Drug Administration Schedule
2
2020
785
0.050
Why?
Cardiovascular Agents
1
2025
160
0.050
Why?
Algorithms
3
2020
1690
0.050
Why?
Carcinoembryonic Antigen
1
2002
39
0.050
Why?
Antigens, Differentiation
1
2002
83
0.050
Why?
Child
5
2020
21819
0.050
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Antigens, Bacterial
1
2002
129
0.040
Why?
Cell Adhesion Molecules
1
2002
181
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
33
0.040
Why?
Insurance Claim Reporting
1
2020
24
0.040
Why?
Antidepressive Agents
1
2022
235
0.040
Why?
Lymphocyte Count
1
2020
150
0.040
Why?
Morbidity
1
2020
323
0.040
Why?
Antigens, Neoplasm
1
2002
319
0.040
Why?
Membrane Glycoproteins
1
2002
500
0.040
Why?
Antineoplastic Agents
1
2010
2123
0.040
Why?
Grounded Theory
1
2019
34
0.040
Why?
Metoprolol
1
2019
40
0.040
Why?
Antigens, CD
1
2002
521
0.040
Why?
Aftercare
1
2020
207
0.040
Why?
Bias
1
2020
218
0.040
Why?
Genomics
1
2024
790
0.040
Why?
HIV Infections
1
2013
2828
0.040
Why?
Mice, Transgenic
1
2023
2163
0.040
Why?
Coronary Angiography
1
2020
311
0.040
Why?
Delivery of Health Care, Integrated
1
2020
255
0.030
Why?
Amino Acid Sequence
2
2002
2138
0.030
Why?
Static Electricity
1
1997
118
0.030
Why?
Exercise Test
1
2020
625
0.030
Why?
Molecular Sequence Data
2
2002
2894
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
80
0.030
Why?
Inpatients
1
2021
496
0.030
Why?
Focus Groups
1
2019
515
0.030
Why?
Frail Elderly
1
2017
132
0.030
Why?
Socioeconomic Factors
1
2020
1282
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
346
0.030
Why?
Metabolic Networks and Pathways
1
2017
180
0.030
Why?
Puerperal Disorders
1
2016
32
0.030
Why?
Physician-Patient Relations
1
2020
548
0.030
Why?
World Health Organization
1
2016
123
0.030
Why?
Neoplasms
1
2010
2643
0.030
Why?
Drug Combinations
1
2016
343
0.030
Why?
Decision Trees
1
2015
93
0.030
Why?
Data Mining
1
2015
116
0.030
Why?
Cell Membrane
1
1997
735
0.030
Why?
Blood Pressure
1
2020
1774
0.030
Why?
Biopsy
1
2017
1124
0.030
Why?
Reproducibility of Results
1
2020
3265
0.020
Why?
Pediatrics
1
2020
1094
0.020
Why?
Models, Genetic
1
2015
599
0.020
Why?
Infant
2
2015
9395
0.020
Why?
Mass Screening
2
2013
1267
0.020
Why?
Liver
1
2020
1940
0.020
Why?
Anthracyclines
1
2010
42
0.020
Why?
Child, Preschool
2
2015
10997
0.020
Why?
Trastuzumab
1
2010
95
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
92
0.020
Why?
Signal Transduction
1
2023
5077
0.020
Why?
Clinical Trials as Topic
1
2015
1044
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
201
0.020
Why?
Program Evaluation
1
2013
889
0.020
Why?
Apoptosis
1
2017
2552
0.020
Why?
Injections, Intravenous
1
2007
207
0.020
Why?
Natriuretic Peptide, Brain
1
2007
99
0.020
Why?
Ultrasonography
1
2010
752
0.020
Why?
Infusions, Intravenous
1
2007
412
0.020
Why?
Mice
1
2023
17759
0.020
Why?
Creatinine
1
2007
499
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2010
801
0.010
Why?
Hospitals, University
1
2005
182
0.010
Why?
Dentists
1
2004
20
0.010
Why?
Femur Neck
1
2004
60
0.010
Why?
Bone Diseases, Metabolic
1
2004
62
0.010
Why?
Antibodies, Monoclonal
1
2010
1430
0.010
Why?
Absorptiometry, Photon
1
2004
254
0.010
Why?
Nurses
1
2005
176
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
26
0.010
Why?
Analysis of Variance
1
2004
1316
0.010
Why?
HeLa Cells
1
2002
633
0.010
Why?
Bone Density
1
2004
487
0.010
Why?
Binding Sites
1
2002
1301
0.010
Why?
Clinical Competence
1
2005
1094
0.010
Why?
Physicians
1
2005
907
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)